Medical Decision Making

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elkin, E. B.
Right arrow Articles by Kattan, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elkin, E. B.
Right arrow Articles by Kattan, M. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Medical Decision Making, Vol. 24, No. 5, 504-510 (2004)
DOI: 10.1177/0272989X04268954
© 2004 Society for Medical Decision Making

Preference Assessment Method Affects Decision-Analytic Recommendations: A Prostate Cancer Treatment Example

Elena B. Elkin, PhD

Departments of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York

Mark E. Cowen, MD

Daniel Cahill, MD

St. Joseph Mercy Hospital, Ann Arbor, Michigan

Mary Steffel

Columbia University, New York

Michael W. Kattan, PhD

Departments of Biostatistics and Epidemiology and Urology, Memorial Sloan-Kettering Cancer Center, New York; Department of Biostatistics and Epidemiology, Wb4, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195; phone: 216-444-0584; fax: 630-604-3605kattanm{at}ccf.org

Purpose. To evaluate the effect of preference assessment method on treatment recommended by an individualized decision-analytic model for early prostate cancer. Methods. Health state preferences were elicited by time tradeoff, rating scale, and a power transformation of the rating scale from 63 men ages 55 to 75. The authors used these values in a Markov model to determine whether radical prostatectomy or watchful waiting yielded the greater quality-adjusted life expectancy. Results. Time tradeoff and transformed rating scale recommendations differed widely. Time tradeoff and transformed rating scale utilities differed in their treatment recommendation for 21% to 52% of men, and the mean difference in quality-adjusted life years varied from less than 0.5 to greater than 1.0. Conclusions. Treatment recommendations from the prostate cancer decision model were sensitive to the method of preference assessment. If decision analysis is used to counsel individual patients, careful considerationmust be given to the method of preference elicitation.

Key Words: preference assessment method • decision-analytic model • prostate cancer • time tradeoff • rating scale • quality-adjusted life expectancy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
M. Holmes-Rovner, W. L. Nelson, M. Pignone, G. Elwyn, D. R. Rovner, A. M. O'Connor, A. Coulter, and R. Correa-de-Araujo
Are Patient Decision Aids the Best Way to Improve Clinical Decision Making? Report of the IPDAS Symposium
Med Decis Making, October 1, 2007; 27(5): 599 - 608.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
W. L. Nelson, P. K. J. Han, A. Fagerlin, M. Stefanek, and P. A. Ubel
Rethinking the Objectives of Decision Aids: A Call for Conceptual Clarity
Med Decis Making, October 1, 2007; 27(5): 609 - 618.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
K. E. Bremner, C. A. K. Y. Chong, G. Tomlinson, S. M. H. Alibhai, and M. D. Krahn
A Review and Meta-Analysis of Prostate Cancer Utilities
Med Decis Making, May 1, 2007; 27(3): 288 - 298.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. C. Miller, S. B. Gruber, B. K. Hollenbeck, J. E. Montie, and J. T. Wei
Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
J Natl Cancer Inst, August 16, 2006; 98(16): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
J. H. Goldberg
Being there is important, but getting there matters too: the role of path in the valuation process.
Med Decis Making, July 1, 2006; 26(4): 323 - 337.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
M. S. Yi
The Implications of Differing Methods of Utility Assessment for Patient-Specific Decision-Analytic Tools
Med Decis Making, October 1, 2004; 24(5): 536 - 537.
[PDF]